The Binding Site of Neuropeptide Vasopressin V1a Receptor

LIGAND: A versatile computerized approach for characterization of ligand-binding systems

Munson, P. J., & Rodbard, D. (1980) · Analytical Biochemistry · doi:10.1016/0003-2697(80)90515-1 · Cited by 8,373

Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy

Henderson, R. A., Baldwin, J. M., Ceska, T. A., Zemlin, F., Beckmann, E., & Downing, K. H. (1990) · Journal of Molecular Biology · doi:10.1016/s0022-2836(05)80271-2 · Cited by 2,982

Lithium amplifies agonist-dependent phosphatidylinositol responses in brain and salivary glands

Berridge, M. J., Downes, C. P., & Hanley, M. R. (1982) · Biochemical Journal · doi:10.1042/bj2060587 · Cited by 2,130

STRUCTURE AND FUNCTION OF G PROTEIN-COUPLED RECEPTORS

Strader, C. D., Fong, T. M., Tota, M. R., Underwood, D. J., & Dixon, R. A. F. (1994) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.63.070194.000533 · Cited by 1,080

The probable arrangement of the helices in G protein‐coupled receptors.

Baldwin, J. M. (1993) · The EMBO Journal · doi:10.1002/j.1460-2075.1993.tb05814.x · Cited by 968

Molecular cloning and expression of a receptor for human tumor necrosis factor

Schall, T. J., Lewis, M., Koller, K. J., Lee, A. L., Rice, G. C., Wong, G. H., Gatanaga, T., Granger, G. A., Lentz, R., Raab, H. E., et al. (1990) · Cell · doi:10.1016/0092-8674(90)90816-w · Cited by 958

Projection structure of rhodopsin

Schertler, G. F. X., Villa, C., & Henderson, R. A. (1993) · Nature · doi:10.1038/362770a0 · Cited by 766

Structure and expression of a human oxytocin receptor

Kimura, T., Tanizawa, O., Mori, K., Brownstein, M., & Okayama, H. (1992) · Nature · doi:10.1038/356526a0 · Cited by 631

Molecular cloning of the receptor for human antidiuretic hormone

Birnbaumer, M., Seibold, A. M., Gilbert, S., Ishido, M., Barberis, C., Antaramián, A., Brabet, P., & Rosenthal, W. (1992) · Nature · doi:10.1038/357333a0 · Cited by 539

Conserved aspartic acid residues 79 and 113 of the beta-adrenergic receptor have different roles in receptor function.

Strader, C. D., Sigal, I. S., Candelore, M. R., Rands, E., Hill, W. S., & Dixon, R. A. F. (1988) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)81509-0 · Cited by 534

In Vitro Mutagenesis Studies of Melanocortin Receptor Coupling and Ligand Binding

Haskell‐Luevano, C. (2000) · Humana Press eBooks · doi:10.1007/978-1-59259-031-5_9 · Cited by 5

Peptidomimetic and Nonpeptide Drug Discovery: Receptor, Protease, and Signal Transduction Therapeutic Targets

Sawyer, T. K. (2007) · Elsevier eBooks · doi:10.1016/b0-08-045044-x/00052-3 · Cited by 4

Prediction of molecular interactions and physicochemical properties relevant for vasopressin V2 receptor antagonism

Veulens, A. D. L. N., Ginarte, Y. M. Á., Fernandez, R. E. R., Leclerc, F., & Montero, L. A. (2022) · Journal of Molecular Modeling · doi:10.1007/s00894-021-05022-6 · Cited by 4

Synthesis and Investigation of the Antidepressant Properties of Novel Analogs of Arginine-Vasopressin

Бородина, К. В., Savanets, O. N., Pustyulga, E. S., Мартинович, В. П., Kravchenko, E. V., Olgomets, L. M., & Golubovich, V. P. (2022) · Russian Journal of Bioorganic Chemistry · doi:10.1134/s1068162022030050 · Cited by 4

Functional Study of Two V2 Vasopressin Mutant Receptors Related to NDI

Morin, D., Ala, Y., Sabatier, N., de la Cotte, N., Hendy, G. N., Vargas‐Poussou, R., Déchaux, M., Antignac, C., Hibert, M., Bichet, D. G., et al. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_50 · Cited by 4

Molecular modeling of the oxytocin receptor/bioligand interactions.

Politowska, E., Czaplewski, C. R., & Ciarkowski, J. (1999) · Acta Biochimica Polonica · doi:10.18388/abp.1999_4130 · Cited by 4

Micelle-bound conformations of neurohypophyseal hormone analogues modified with a Cα-disubstituted residue: NMR and molecular modelling studies

Sikorska, E., & Kwiatkowska, A. (2012) · Journal of Biomolecular Structure and Dynamics · doi:10.1080/07391102.2012.709459 · Cited by 4

The action of fish peptide Orpotrin analogs on microcirculation

Conceição, K., Bruni, F. M., dos Santos, J. M., Lopes, R. M., Marques, E. E., Fernández, J. H., & Lopes‐Ferreira, M. (2010) · Journal of Peptide Science · doi:10.1002/psc.1311 · Cited by 4

Putative Dynamics of Vasopressin in its V1a Receptor Binding Site

Kaltenböck, A., Hibert, M., & Langer, T. (2003) · Receptors and Channels · doi:10.1080/10606820308251 · Cited by 4

DOCKING LIGANDS TO VASOPRESSIN AND OXYTOCIN RECEPTORS VIA GENETIC ALGORITHM

Politowska, E., Drabik, P., Kaźmierkiewicz, R., & Ciarkowski, J. (2002) · Journal of Receptors and Signal Transduction · doi:10.1081/rrs-120014609 · Cited by 4

Extracellular loop 3 (ECL3) and ECL3-proximal transmembrane domains VI and VII of the mesotocin and vasotocin receptors confer differential ligand selectivity and signaling activity

Cho, H.-J., Moon, M. J., Kwon, H. B., Hwang, J., & Seong, J. Y. (2007) · General and Comparative Endocrinology · doi:10.1016/j.ygcen.2007.11.010 · Cited by 4

Identification of a Constitutively Active Mutant of the Human Oxytocin Receptor

Chini, B., Albertazzi, E., de Benedetti, P., & Fanelli, F. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_47 · Cited by 4

Structural plasticity of arrestin-G protein coupled receptor complexes as a molecular determinant of signaling

Felline, A., Bellucci, L., Vezzi, V., Ambrosio, C., Cotecchia, S., & Fanelli, F. (2024) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2024.137217 · Cited by 3

Molecular modeling of vasopressin receptor andin silicoscreening of V1b receptor antagonists

Hagiwara, Y., Ohno, K., Kamohara, M., Takasaki, J., Watanabe, T., Fukunishi, Y., Nakamura, H., & Orita, M. (2013) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2013.799134 · Cited by 3

Nonapeptide Evolution and the Regulation of Social Behaviour in Teleost Fish: From Molecules to Sociality

Kareklas, K., Sorigue, P., & Oliveira, R. F. (2025) · Masterclass in neuroendocrinology · doi:10.1007/978-3-031-80209-6_15 · Cited by 3

Two-Photon Permeabilization and Calcium Measurements in Cellular Organelles

Gerasimenko, O. V., & Gerasimenko, J. V. (2009) · Methods in molecular biology · doi:10.1007/978-1-60761-404-3_12 · Cited by 3

Synthesis of new vasotocin analogues: effects on renal water and ion excretion in rats

Кутина, А. В., Marina, A. S., Eliseev, I. I., Titov, M. I., & IuV, N. (2013) · Journal of Peptide Science · doi:10.1002/psc.2495 · Cited by 3

Theoretical studies, synthesis, and biological activity of 1-[(4-methylphenyl)sulfonyl]-5-oxo-2,3,4,5-tetrahydro-1H-1-benzazepine-4-carbonitrile (C9) as a non-peptide antagonist of the arginine vasopressin V1a and V2 receptors

Contreras‐Romo, M. C., Correa‐Basurto, J., Martínez, I. I. P., Martínez‐Archundia, M., Martı́nez-Ramos, F., Ślusarz, M. J., López-Pérez, G., & Quintanar‐Stephano, A. (2013) · Medicinal Chemistry Research · doi:10.1007/s00044-013-0739-5 · Cited by 3

Polyuria and Diabetes Insipidus

Bichet, D. G. (2012) · Elsevier eBooks · doi:10.1016/b978-0-12-381462-3.00046-x · Cited by 3

Chapter 13 Expression of human vasopressin and oxytocin receptors in Escherichia coli

Mouillac, B., Sen, T., Durroux, T., Gaibelet, G., & Barberis, C. (2002) · Progress in brain research · doi:10.1016/s0079-6123(02)39015-0 · Cited by 3

Virtual Screening on Homology Models

Kiss, R., & Keserű, G. M. (2011) · Methods and principles in medicinal chemistry · doi:10.1002/9783527633326.ch14 · Cited by 3

Posterior Pituitary Hormones

Bichet, D. G. (2007) · Humana Press eBooks · doi:10.1007/978-1-59259-829-8_14 · Cited by 3

On the spatial disposition of the fifth transmembrane helix and the structural integrity of the transmembrane binding site in the opioid and ORL1 G protein-coupled receptor family

Topham, C. M., Moulédous, L., & Meunier, J. (2000) · Protein Engineering Design and Selection · doi:10.1093/protein/13.7.477 · Cited by 3

Spatial and Temporal Control of Calcium Signaling by NAADP

Churchill, G. C., Patel, S., Thomas, J. M., & Galione, A. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0269-2_10 · Cited by 3

Correlation of renal solute-free water reabsorption and energy of interaction of vasotocin analogs with V2 receptor

Кутина, А. В., Karavashkina, T. A., Ei, S., Gao, J., Mordvintsev, D. Y., Kuzmin, D., Tsetlin, V. I., & IuV, N. (2011) · Biology Bulletin · doi:10.1134/s1062359011060057 · Cited by 2

An Influence of the Aromatic Side Chains Conformations in Positions 2 and 3 of Vasopressin Analogs on Interactions with Vasopressin and Oxytocin Receptors

Ślusarz, R., & Ślusarz, M. J. (2009) · QSAR & Combinatorial Science · doi:10.1002/qsar.200810164 · Cited by 2

Effects of Intracerebroventricularly Administered Carbetocin on Social Behavior in Holstein Steers

Yayou, K., Ito, S., Kasuya, E., Sutoh, M., & Yamamoto, N. (2013) · Journal of Veterinary Medical Science · doi:10.1292/jvms.12-0560 · Cited by 2

A novel disease-causing mutation in AVPR2: Q96H

Lemaire, M. J., Chitayat, D. A., Geary, D. F., Bichet, D. G., & Licht, C. P. B. (2008) · Clinical Kidney Journal · doi:10.1093/ndtplus/sfn163 · Cited by 2

Nephrogenic Diabetes Insipidus

Bichet, D. G. (2009) · Elsevier eBooks · doi:10.1016/b978-0-12-449851-8.00021-8 · Cited by 2

Vasopressin V2 Receptor/Bioligand Interactions

Czaplewski, C. R., Kaźmierkiewicz, R., & Ciarkowski, J. (1998) · Letters in Peptide Science · doi:10.1007/bf02443481 · Cited by 2

Diversity of nephrogenic diabetes insipidus mutations and importance of early recognition and treatment

Bichet, D. G., & Fujiwara, T. (1998) · Clinical and Experimental Nephrology · doi:10.1007/bf02480451 · Cited by 2

Regional differences in oxytocin and vasopressin 1a receptor functionality in mouse embryonic brain development

Sommer, E., & Caldwell, H. K. (2025) · Neuroscience Letters · doi:10.1016/j.neulet.2025.138409 · Cited by 1

Modeling the human oxytocin receptor for drug discovery efforts

Jójárt, B., Balogh, B., & Márki, Á. (2007) · Expert Opinion on Drug Discovery · doi:10.1517/17460441.2.12.1579 · Cited by 1

Analogues of arginine vasopressin modified at position 2 with proline derivatives: selective antagonists of oxytocin in vitro

Sobolewski, D., Prahl, A., Slaninová, J., & Lammek, B. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-0-387-73657-0_218 · Cited by 1

Polyuria and Diabetes Insipidus

Bichet, D. G. (2008) · Elsevier eBooks · doi:10.1016/b978-012088488-9.50046-2 · Cited by 1

Computer aided study of the oxytocin - receptor complex binding sites

Miladinova, E., Petkov, P., Ilieva, N., & Litov, L. (2020) · SDRP Journal of Computational Chemistry & Molecular Modelling · doi:10.25177/jccmm.4.2.ra.10605 · Cited by 1

The Posterior Pituitary

Bichet, D. G. (2022) · Elsevier eBooks · doi:10.1016/b978-0-323-99899-4.00020-2 · Cited by 1

Epithelial Ion Channel Folding and ER-Associated Degradation (ERAD)

Buck, T. M., & Brodsky, J. L. (2020) · Physiology in health and disease · doi:10.1007/978-3-030-52780-8_7 · Cited by 1

Three-dimensional structure of G protein-coupled receptors: from speculations to facts

Hibert, M., Hoflack, J., Trumpp‐Kallmeyer, S., Paquet, J., Leppik, R. A., Mouillac, B., Chini, B., Barberis, C., & Jard, S. (1996) · Pharmacochemistry library · doi:10.1016/s0165-7208(96)80017-1 · Cited by 1

Multifunctional chimeric analogs of small peptide hormones: Agonists and receptor-selective antagonists

Howl, J., & Wheatley, M. (2005) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46862-x_261 · Cited by 1

Cardiac arrest: a role for vasopressin

Shehab, A. M. A., & Kendall, M. J. (2004) · Journal of Clinical Pharmacy and Therapeutics · doi:10.1111/j.1365-2710.2004.00566.x · Cited by 1

Coenzymes of Oxidation—Reduction Reactions

Metzler, D. E., Metzler, C. M., & Sauke, D. J. (2001) · Elsevier eBooks · doi:10.1016/b978-012492543-4/50018-0 · Cited by 1

Subtype selective activation and molecular characterization of galanin receptors

Lundström, L. (2007) · KTH Publication Database DiVA (KTH Royal Institute of Technology)

Diabetes insípidas nefrógenas

Bichet, D. G. (2007) · EMC - Pediatría · doi:10.1016/s1245-1789(07)70249-4

Theoretical Study on Interactions of Bicyclic Vasopressin Analogues with Human Neurohypophyseal Hormone Receptors

Ślusarz, R., Sikorska, E., & Ślusarz, M. J. (2008) · QSAR & Combinatorial Science · doi:10.1002/qsar.200710173

Étude fonctionnelle de mutations du gène du récepteur V2 responsables d'un diabète insipide néphrogénique congénital

Morin, D., Ala, Y., Vargas‐Poussou, R., Sabatier, N., Antignac, C., Déchaux, M., Loirat, C., Broyer, M., Dumas, R., Bichet, D. G., et al. (1997) · Archives de Pédiatrie · doi:10.1016/s0929-693x(97)86514-1

Mechanisms of arginine vasopressin- and oxytocin-induced glucagon release

Yibchok‐anun, S. (1999) · doi:10.31274/rtd-180813-13463

Cross-talk between the Oxytocin and Vasopressin Systems in the Brian: Roles in Social Behavior

Song, Z. (2022) · Digital Archive @ GSU · doi:10.57709/7996120

Optimization of Vasopressin Type 2 Receptor Expression in Escherichia coli BL21

Moazen, F., Djabali, P. E., Parsapour, N., Mohamadzadeh, F., Jafarian‐Dehkordi, A., & Hamid, M. (2016) · Jundishapur Journal of Natural Pharmaceutical Products · doi:10.17795/jjnpp-25441

Diabètes insipides néphrogéniques

Bichet, D. G. (2007) · EMC - Pédiatrie - Maladies infectieuses · doi:10.1016/s1637-5017(07)72364-5

Coordination of Calcium Signaling by cADPR and NAADP in Pancreatic Acinar Cells

Cancela, J. (2002) · Springer eBooks · doi:10.1007/978-1-4615-0269-2_17

Molecular pharmacology of vasopressin receptors

Barberis, C., Mouillac, B., Seyer, R., Phalipou, S., de la Cotte, N., Balestre, M., Morin, D., Durroux, T., Hibert, M., & Manning, M. (2006) · Kluwer Academic Publishers eBooks · doi:10.1007/0-306-46881-6_253

Structure of the antidiuretic hormone vasopressin receptor signalling complexPreprint

Bous, J., Orcel, H., Floquet, N., Leyrat, C., Lai‐Kee‐Him, J., Gaibelet, G., Ancelin, A., Saint‐Paul, J., Trapani, S., Louet, M., et al. (2020) · bioRxiv (Cold Spring Harbor Laboratory) · doi:10.1101/2020.12.22.424028

Pharmacological Characterisation of Novel Oxytocin and Vasopressin Receptor Ligands

Gulliver, D. W. (2021) · The Sydney eScholarship Repository (The University of Sydney)

Faculty Opinions recommendation of Hereditary nephrogenic diabetes insipidus: pathophysiology and possible treatment. an update.

Valenti, G., & Tamma, G. (2019) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.732099898.793555510

Rational Approaches and Designing Strategies for Antihypertensive Agents

Vaidya, G. N. (2025) · Springer eBooks · doi:10.1007/978-981-96-4154-3_25

Nonapeptide molecular evolution during the adaptive radiation of Tanganyika cichlids

Sorigue, P., Salzburger, W., & Oliveira, R. F. (2026) · Journal of Neuroendocrinology · doi:10.1111/jne.70203

Etude des bases structurales de l’efficacité et de la sélectivité fonctionnelle des récepteurs couplés aux protéines G : cas du récepteur V2 de la vasopressine

Rahmeh, R. (2010) · theses.fr (ABES) · doi:10.70675/a1c0e871ze67cz4849zba62z57e10a494cd3

Premières toxines Kunitz antagonistes du récepteur de type 2 à la vasopressine : étude pharmacodynamique et relations structure-activité

Droctové, L. (2018) · doi:10.70675/b0250d67zb6efz41f9z8268z72645c624943

Synthèse de peptides bioactifs inspirés des venins

Giribaldi, J. (2019) · theses.fr (ABES) · doi:10.70675/4396528bz40f7z47abz935az5799907cf557

New regulators in oxytocin and vasopressin release : role of the endolysosomal two-pore channels

Martucci, L. L. (2021) · theses.fr (ABES) · doi:10.70675/027d1ae2zd2ebz4677za019ze6ccd94cafe9

A journey toward understanding the vasopressin type 2 receptor function; impact of small molecules and structural biology

Fouillen, A., Couvineau, P., Mouillac, B., & Bous, J. (2026) · Molecular and Cellular Endocrinology · doi:10.1016/j.mce.2026.112835

BindingDB Entry 50011194: Design, synthesis and pharmacological characterization of a potent radioiodinated and photoactivatable peptidic oxytocin antagonist.

BindingDB (2009) · UC San Diego · doi:10.7270/q29s1q9f

BindingDB Entry 50037587: Design of benzophenone-containing photoactivatable linear vasopressin antagonists: pharmacological and photoreactive properties.

BindingDB (2012) · UC San Diego · doi:10.7270/q2sj1mdg

BindingDB Entry 50037312: Design of potent and selective agonists for the human vasopressin V1b receptor based on modifications of [deamino-cys1]arginine vasopressin at position 4.

BindingDB (2012) · UC San Diego · doi:10.7270/q2gf0v8c

BindingDB Entry 50036518: Biological and conformational examination of stereochemical modifications using the template melanotropin peptide, Ac-Nle-c[Asp-His-Phe-Arg-Trp-Ala-Lys]-NH2, on human melanocortin receptors.

BindingDB (2012) · UC San Diego · doi:10.7270/q29k4bwk

BindingDB Entry 50037964: Toward efficient drug screening by homogeneous assays based on the development of new fluorescent vasopressin and oxytocin receptor ligands.

BindingDB (2012) · UC San Diego · doi:10.7270/q24x58nw

BindingDB Entry 50039043: Subtlety of the structure-affinity and structure-efficacy relationships around a nonpeptide oxytocin receptor agonist.

BindingDB (2012) · UC San Diego · doi:10.7270/q2fx7bd4

BindingDB Entry 50008646: Fluorescent pseudo-peptide linear vasopressin antagonists: design, synthesis, and applications.

BindingDB (2009) · UC San Diego · doi:10.7270/q2057f3q

BindingDB Entry 50037030: Synthesis and characterization of fluorescent antagonists and agonists for human oxytocin and vasopressin V(1)(a) receptors.

BindingDB (2012) · UC San Diego · doi:10.7270/q2w37x10

Identification of agonist binding sites of vasopressin and oxytocin receptors.

Mouillac, B., Chini, B., Balestre, M., Jard, S., Barberis, C., Manning, M., Tribollet, E., Trumpp-Kallmeyer, S., Hoflack, J., & Elands, J. (1995) · PubMed · Cited by 25

Mapping Peptide Antagonist Binding Sites of the Human V1a and V2 Vasopressin Receptors

Mouillac, B., Phalipou, S., de la Cotte, N., Balestre, M., Hibert, M., Manning, M., & Barberis, C. (1998) · Advances in experimental medicine and biology · doi:10.1007/978-1-4615-4871-3_45 · Cited by 6

Mapping the Binding Site of Arginine Vasopressin to V 1a and V 1b Vasopressin Receptors

Rodrigo, J., Peña, A., Murat, B., Trueba, M., Durroux, T., Guillon, G., & Rognan, D. (2006) · Molecular Endocrinology · doi:10.1210/me.2006-0202 · Cited by 43

Agonist binding to peptide hormone receptors

Wheatley, M., Hawtin, S. R., Wesley, V. J., Howard, H. C., Simms, J., Miles, A., McEwan, K., & Parslow, R. A. (2003) · Biochemical Society Transactions · doi:10.1042/bst0310035 · Cited by 13

A Single Residue (Arg46) Located Within the N-Terminus of the V1a Vasopressin Receptor Is Critical for Binding Vasopressin But Not Peptide or Nonpeptide Antagonists

Hawtin, S. R., Wesley, V. J., Parslow, R. A., Simms, J., Miles, A., McEwan, K., & Wheatley, M. (2002) · Molecular Endocrinology · doi:10.1210/mend.16.3.0795 · Cited by 25